Ondansetron HCL 4 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FX1FT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,066
Award facts
- Contract value 100% obligated
- $12,065.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,065.60 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for Ondansetron HCL 4mg, 30-count supply, with ultimate completion on March 13, 2026.
The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside.
Quick answers
Who was awarded contract SPE2DR26FX1FT?
SPE2DR26FX1FT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 12, 2026.
How much is contract SPE2DR26FX1FT worth?
The government has obligated $12,066 on SPE2DR26FX1FT.
Is contract SPE2DR26FX1FT an order under another contract?
Yes. SPE2DR26FX1FT is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX1FT competed?
The extent of competition for SPE2DR26FX1FT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award